对于威尔逊病的肝移植:当前的知识和未来的前景
Alberto Ferrarese1, Nora Cazzagon2, Patrizia Burra1,2
1Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, Padua University Hospital, Padua, Italy.
概括
肝移植是威尔逊病 (WD) 患有严重肝脏问题的患者的成功治疗方法. 扩大标准,包括精选的神经精神病例,有望改善铜平衡和神经症状.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 移植手术 移植手术
- 神经学 神经学
背景情况:
- 威尔逊病 (WD) 是一种铜代谢的遗传性疾病.
- 肝移植是建立的末期肝病和急性肝衰竭在WD.
- 最近的重点是扩大WD的移植指示.
研究的目的:
- 审查目前肝移植在威尔逊病中的作用.
- 为了探索神经精神病威尔逊病的移植的潜力.
- 确定挑战,并为WD移植评估提出一种特定疾病的方法.
主要方法:
- 对威尔逊病肝移植现有文献的综述.
- 对末期肝病和急性肝衰竭患者的结局分析.
- 讨论支持神经精神病症状和补偿性肝硬化移植的证据.
主要成果:
- 肝移植在WD患者中显示出出色的生存率,尤其是没有复发的年轻患者.
- 移植可以改善铜恒温和改善神经精神症状在选定的WD患者.
- 关于神经精神病WD的移植前评估和术后结果定义的关键问题仍然存在.
结论:
- 肝移植是威尔逊病中晚期肝病的可行选择.
- 精心选择神经精神病威尔逊病患者可能会从移植中受益.
- 对于威尔逊病移植评估和管理,需要采用标准化,疾病特异性的方法.
相关概念视频
Diseases of the Liver and Gallbladder
2.1K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
382
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
382
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
271
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
Kidney Transplant I: Introduction
827
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
827
Cirrhosis II: Pathophysiology
42
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
42


